Document is current
Any future updates will be listed below
-
Authors
Darling, Andrea L.
Middleton, Benita A.
Gossiel, Fatma
Eastell, Richard
Lanham-New, Susan A.
Skene, Debra J.
-
Funding
Funding for this research was provided by:
Royal Osteoporosis Society (420, 420, 420, 420)
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 19 August 2025
First Online: 25 September 2025
Declarations
:
: D.J.S. and B.M. are past Co-Directors of Stockgrand Ltd. R.E. receives consultancy funding from Immunodiagnostic Systems, Sandoz, Samsung, CL Bio, Biocon, Takeda, UCB, meeting presentations for Pharmacosmos, Alexion, UCB and Amgen, and grant funding from Alexion. A.L.D and F.G. have nothing to disclose. S.L.N. reports being a member of the main SACN Committee (2010 to present) and the SACN Vitamin D Working Group (2010–2016; 2022-present) and also the European Food Safety Authority (EFSA) Committee on the Tolerable Upper Limit for Vitamin D (2021–2023). S.L.N. is Research Director of D3Tex Ltd which holds the UK and Gulf Corporation Council Patents for the use of UVB material for combatting vitamin D deficiency in women who dress for cultural style. All the remaining authors declare no conflict of interest.
